141 related articles for article (PubMed ID: 6185854)
1. HLA-DR products are a subset of human Ia antigens.
Makgoba MW; Fuggle SV; McMichael AJ; Morris PJ
Nature; 1983 Feb; 301(5900):531-2. PubMed ID: 6185854
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region.
Nadler LM; Stashenko P; Hardy R; Tomaselli KJ; Yunis EJ; Schlossman SF; Pesando JM
Nature; 1981 Apr; 290(5807):591-3. PubMed ID: 6163992
[TBL] [Abstract][Full Text] [Related]
3. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
4. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
5. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
Johnson JP; Wank R
Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
[TBL] [Abstract][Full Text] [Related]
6. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
Shaw S; Ziegler A; DeMars R
Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of Ia molecules by human monocytes.
Gonwa TA; Stobo JD
J Clin Invest; 1984 Sep; 74(3):859-66. PubMed ID: 6432851
[TBL] [Abstract][Full Text] [Related]
8. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
9. HLA-DS molecules and their relation to supertypic specificities.
Goyert SM; Moriuchi J; Winchester R; Silver J
Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
[TBL] [Abstract][Full Text] [Related]
10. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies against determinants on human MHC class II antigens].
Eichler W; Seifert M; Fiebig H
Allerg Immunol (Leipz); 1990; 36(4):309-20. PubMed ID: 1711285
[TBL] [Abstract][Full Text] [Related]
12. Human 'Ia' antigen populations defined by monoclonal antibodies.
Sparrow RL; McKenzie IF
J Immunogenet; 1983 Jun; 10(3):179-89. PubMed ID: 6192177
[TBL] [Abstract][Full Text] [Related]
13. The distribution of DR5, MT2, and MB3 specificities on human Ia subsets.
Tanigaki N; Tosi R; Sagawa K; Minowada J; Ferrara GB
Immunogenetics; 1983; 17(4):371-86. PubMed ID: 6187679
[TBL] [Abstract][Full Text] [Related]
14. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
15. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
[TBL] [Abstract][Full Text] [Related]
16. Mouse monoclonal anti-Ia antibodies recognize cross-reacting determinants expressed on distinct subsets of human Ia-like cell-surface molecules.
Birnbaum D; Rohner C; Dubreuil P; Bourgue F; Pierres M; Goridis C
Mol Immunol; 1983 May; 20(5):511-20. PubMed ID: 6192324
[TBL] [Abstract][Full Text] [Related]
17. Identification of a human Ia antigen that is different from HLA-DR and DC antigens.
Makgoba MW; Hildreth JE; McMichael AJ
Immunogenetics; 1983; 17(6):623-35. PubMed ID: 6407986
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of human Ia antigens reveals the existence of a fourth molecular subset distinct from DP, DQ, and DR molecules.
Carra G; Accolla RS
J Exp Med; 1987 Jan; 165(1):47-63. PubMed ID: 2432152
[TBL] [Abstract][Full Text] [Related]
19. A new polymorphic determinant on HLA-DQ molecules.
Shipp MA; Ahmed P; Kannapell CC; Ford JC; McCourt D; Leykam JF; Zacheis M; Bono C; Davie JM; Mustain E
Hum Immunol; 1986 May; 16(1):24-37. PubMed ID: 2423485
[TBL] [Abstract][Full Text] [Related]
20. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
